Epstein-Barr virus infection - life cycle, methods of diagnosis, associated diseases

被引:21
作者
Bocian, Joanna [1 ]
Januszkiewicz-Lewandowska, Danuta [2 ,3 ,4 ]
机构
[1] Zaklad Diagnost Med, PL-60595 Poznan, Poland
[2] Inst Genet Czlowieka PAN, Poznaniu, Poland
[3] Zaklad Diagnost Med, Poznaniu, Poland
[4] Uniwersytet Med, K Marcinkowskiego Klin Onkol Hematol & Transplant, Poznaniu, Poland
来源
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ | 2011年 / 65卷
关键词
Epstein-Barr virus; genome; viral proteins; EBV-associated neoplasms; diagnosis; CANCER;
D O I
10.5604/17322693.943104
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Epstein-Barr virus (EBV) is a ubiquitous virus that infects about 90-95% of the adult population. EBV establishes life-long latent persistence. The virus is found to be the major cause of infectious mononucleosis but it has also been associated with development of endemic Burkitt's lymphoma. Result of EBV infection is the most common complication in patients after transplantation which is a post-transplant lymphoproliferative disease. Strong associations between EBV infection and Hodgkin's lymphoma, nasopharyngeal carcinoma, gastric carcinoma and carcinomas derived from smooth muscle tissue also exist. There is a hypothesis that there is an association between EBV infection and autoimmune and allergic diseases. EBV is a Herpesvirus family member; its genetic material has dsDNA form. There are two strains of EBV: A and B. The only host for EBV is human with target cells: B cells and epithelial cells. The life cycle of EBV consists of lytic and latent phases. In the latent phase three different patterns of gene expression are possible. Due to some circumstances EBV can undergo reactivation, which is an important issue in transplantology. The main methods of diagnosis of EBV infections are serological methods that detect certain specific antibodies and recently more popular molecular biological methods such as PCR or in situ hybridization.
引用
收藏
页码:286 / 298
页数:13
相关论文
共 24 条
[1]  
AALTO S, 2011, MODERN DIAGNOSIS EPS
[2]  
Bienias J, 2007, POSTEP MIKROBIOL, V46, P153
[3]   Detection of Epstein-Barr virus in invasive breast cancers [J].
Bonnet, M ;
Guinebretiere, JM ;
Kremmer, E ;
Grunewald, V ;
Benhamou, E ;
Contesso, G ;
Joab, I .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (16) :1376-1381
[4]   Biology and disease associations of Epstein-Barr virus [J].
Crawford, DH .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2001, 356 (1408) :461-473
[5]  
Dobrzanska J, 2006, ONCOL CLIN PRACT, V2, P64
[6]   Themed issue: the biology and pathology of the Epstein-Barr virus [J].
Murray, PG ;
Young, LS .
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 2000, 53 (05) :219-221
[7]  
Glaser SL, 2004, CANCER EPIDEM BIOMAR, V13, P688
[8]   Routine Epstein-Barr virus diagnostics from the laboratory perspective: Still challenging after 35 years [J].
Hess, RD .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (08) :3381-3387
[9]  
Juszczynski Przemyslaw, 2003, Acta Haematologica Polonica, V34, P277
[10]   The lytic cycle of Epstein-Barr virus is associated with decreased expression of cell surface major histocompatibility complex class I and class II molecules [J].
Keating, S ;
Prince, S ;
Jones, M ;
Rowe, M .
JOURNAL OF VIROLOGY, 2002, 76 (16) :8179-8188